Comparative Biosciences Inc. is committed to providing expert resources and quality service to all sectors of the biomedical community. Extensive experience in the biotechnology and pharmaceutical industries provide our staff with a solid track record in both preclinical activities and drug development capabilities.
Comparative Biosciences, Inc. provides state of-the-art toxicology, pharmacokinetics, pharmacology, and efficacy studies. Toxicology studies include acute, subacute and chronic GLP and nonGLP studies aand pharmacokinetic/pharmacodynamic studies in all species including mice, rats, hamsters, guinea pigs, rabbits, dogs, and pigs. We offer a wide range of pharmacology capabilities including ocular, dermal, inflammatory, immune mediated, cardiovascular, xenograft, anti-infection, and metabolic efficacy modeling, The histopathology laboratory provides comprehensive GLP and research histology and pathology, including tissue cross reactivity, special stains, immunohistochemistry, plastics, and image analysis.
Our new, state-of-the-art facilities includes laboratories, vivarium, surgery, tissue culture, histology, on site board certified pathologists, image analysis, CT scanning, clinical pathology, and quality assurance. We have FDA, USDA, OLAW registrations, and comply with FDA, OECD and ICH guidelines.
The mission at Comparative Biosciences Inc. is to provide the same level of excellence to the determined biotech startup that we deliver on a scaleable level to the largest pharmaceutical company.
Follow the links on the left to learn more about Comparative Biosciences, Inc., our array of capabilities and services, and our commitment to ongoing excellence in biomedicine.